419 related articles for article (PubMed ID: 29480324)
1. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe O; Ono T; Sato H; Müller F; Ogata H; Miura I; Shikama Y; Yabe H; Onoue S; Fromm MF; Kimura J; Misaka S
Eur J Clin Pharmacol; 2018 Jun; 74(6):775-783. PubMed ID: 29480324
[TBL] [Abstract][Full Text] [Related]
2. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
3. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects.
Misaka S; Yatabe J; Müller F; Takano K; Kawabe K; Glaeser H; Yatabe MS; Onoue S; Werba JP; Watanabe H; Yamada S; Fromm MF; Kimura J
Clin Pharmacol Ther; 2014 Apr; 95(4):432-8. PubMed ID: 24419562
[TBL] [Abstract][Full Text] [Related]
4. Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers.
Misaka S; Ono Y; Taudte RV; Hoier E; Ogata H; Ono T; König J; Watanabe H; Fromm MF; Shimomura K
Clin Pharmacol Ther; 2022 Sep; 112(3):627-634. PubMed ID: 35678032
[TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
Misaka S; Abe O; Sato H; Ono T; Shikama Y; Onoue S; Yabe H; Kimura J
Eur J Clin Pharmacol; 2018 May; 74(5):601-609. PubMed ID: 29368187
[TBL] [Abstract][Full Text] [Related]
6. Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG).
Hu J; Zhou D; Chen Y
J Agric Food Chem; 2009 Feb; 57(4):1349-53. PubMed ID: 19182914
[TBL] [Abstract][Full Text] [Related]
7. An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).
Albassam AA; Markowitz JS
Planta Med; 2017 Apr; 83(6):496-508. PubMed ID: 28118673
[TBL] [Abstract][Full Text] [Related]
8. Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin.
Huang S; Xu Q; Liu L; Bian Y; Zhang S; Huang C; Miao L
Curr Drug Metab; 2020; 21(6):471-478. PubMed ID: 32407265
[TBL] [Abstract][Full Text] [Related]
9. Oral epigallocatechin gallate reduces intestinal nadolol absorption via modulation of Oatp1a5 and Oct1 transcriptional levels in spontaneously hypertensive rats.
Tan HJ; Ling WC; Chua AL; Lee SK
Phytomedicine; 2021 Sep; 90():153623. PubMed ID: 34303263
[TBL] [Abstract][Full Text] [Related]
10. Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers.
Misaka S; Ono Y; Uchida A; Ono T; Abe O; Ogata H; Sato H; Suzuki M; Onoue S; Shikama Y; Shimomura K
Clin Transl Sci; 2021 Mar; 14(2):476-480. PubMed ID: 33048477
[TBL] [Abstract][Full Text] [Related]
11. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities.
Elbling L; Weiss RM; Teufelhofer O; Uhl M; Knasmueller S; Schulte-Hermann R; Berger W; Micksche M
FASEB J; 2005 May; 19(7):807-9. PubMed ID: 15738004
[TBL] [Abstract][Full Text] [Related]
12. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.
Suzuki-Sugihara N; Kishimoto Y; Saita E; Taguchi C; Kobayashi M; Ichitani M; Ukawa Y; Sagesaka YM; Suzuki E; Kondo K
Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777
[TBL] [Abstract][Full Text] [Related]
13. Interactions of green tea catechins with organic anion-transporting polypeptides.
Roth M; Timmermann BN; Hagenbuch B
Drug Metab Dispos; 2011 May; 39(5):920-6. PubMed ID: 21278283
[TBL] [Abstract][Full Text] [Related]
14. Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteers.
Misaka S; Abe O; Ono T; Ono Y; Ogata H; Miura I; Shikama Y; Fromm MF; Yabe H; Shimomura K
Br J Clin Pharmacol; 2020 Nov; 86(11):2314-2318. PubMed ID: 32320490
[TBL] [Abstract][Full Text] [Related]
15. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers.
Kim TE; Ha N; Kim Y; Kim H; Lee JW; Jeon JY; Kim MG
Drug Des Devel Ther; 2017; 11():1409-1416. PubMed ID: 28533679
[TBL] [Abstract][Full Text] [Related]
16. Effects of Green Tea Extract on Atorvastatin Pharmacokinetics in Healthy Volunteers.
Abdelkawy KS; Abdelaziz RM; Abdelmageed AM; Donia AM; El-Khodary NM
Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):351-360. PubMed ID: 31997084
[TBL] [Abstract][Full Text] [Related]
17. Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.
Morin MP; Bedran TB; Fournier-Larente J; Haas B; Azelmat J; Grenier D
BMC Complement Altern Med; 2015 Mar; 15():48. PubMed ID: 25880992
[TBL] [Abstract][Full Text] [Related]
18. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
19. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways.
Pajak B; Kania E; Gajkowska B; Orzechowski A
J Physiol Pharmacol; 2011 Aug; 62(4):449-59. PubMed ID: 22100846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
